{
    "eid": "2-s2.0-85069775657",
    "title": "Drug-drug interactions between feminizing hormone therapy and pre-exposure prophylaxis among transgender women: the iFACT study",
    "cover-date": "2019-07-01",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Public Health, Environmental and Occupational Health",
            "@code": "2739",
            "@abbrev": "MEDI"
        },
        {
            "@_fa": "true",
            "$": "Infectious Diseases",
            "@code": "2725",
            "@abbrev": "MEDI"
        }
    ],
    "keywords": [
        "drug-drug interactions",
        "feminizing hormone",
        "pre-exposure prophylaxis",
        "prevention",
        "transgender women"
    ],
    "authors": [
        "Akarin Hiransuthikul",
        "Rena Janamnuaysook",
        "Kanittha Himmad",
        "Stephen J. Kerr",
        "Narukjaporn Thammajaruk",
        "Tippawan Pankam",
        "Kannapat Phanjaroen",
        "Stephen Mills",
        "Ravipa Vannakit",
        "Praphan Phanuphak",
        "Nittaya Phanuphak"
    ],
    "citedby-count": 53,
    "ref-count": 40,
    "ref-list": [
        "Worldwide burden of HIV in transgender women: a systematic review and meta-analysis",
        "HIV prevalence, risk behavior, hormone use and surgical history among transgender persons in Thailand",
        "HIV surveillance and prevention in transgender women",
        "Characteristics and HIV epidemiologic profiles of men who have sex with men and transgender women in key population-led test and treat cohorts in Thailand",
        "Transgender women, hormonal therapy and HIV treatment: a comprehensive review of the literature and recommendations for best practices",
        "The development of sex reassignment surgery in Thailand: a social perspective",
        "Exploration of functional health, mental well-being and cross-sex hormone use in a sample of Thai male-to-female transgendered persons (kathoeys)",
        "HIV-related risk behaviors among kathoey (male-to-female transgender) sex workers in Bangkok, Thailand",
        "Preexposure chemoprophylaxis for HIV prevention in men who have sex with men",
        "Antiretroviral preexposure prophylaxis for heterosexual HIV transmission in Botswana",
        "Antiretroviral prophylaxis for HIV infection in injecting drug users in Bangkok, Thailand (the Bangkok Tenofovir Study): a randomised, double-blind, placebo-controlled phase 3 trial",
        "HIV pre-exposure prophylaxis in transgender women: a subgroup analysis of the iPrEx trial",
        "Acceptability of pre-exposure prophylaxis among men who have sex with men and transgender women in northern Thailand",
        "Barriers and facilitators to engagement and retention in care among transgender women living with human immunodeficiency virus",
        "\u201cI am not a man\u201d: trans-specific barriers and facilitators to PrEP acceptability among transgender women",
        "HIV risk and preventive interventions in transgender women sex workers",
        "Estrogens and Body Weight Regulation in Men",
        "Body mass index, waist/hip ratio and androgen-estrogen activity in younger versus older Polish men",
        "Center of Excellence for Transgender Health, Department of Family and Community Medicine, University of California San Francisco",
        "Treating a transgender patient: overview of the guidelines",
        "Pharmacokinetic study of tenofovir disoproxil fumarate combined with rifampin in healthy volunteers",
        "Sino-implant (II)(R) continuation and effect of concomitant tenofovir disoproxil fumarate-emtricitabine use on plasma levonorgestrel concentrations among women in Bondo, Kenya",
        "Lack of effect of tenofovir disoproxil fumarate on pharmacokinetics of hormonal contraceptives",
        "Pre-exposure prophylaxis for HIV-1 prevention does not diminish the pregnancy prevention effectiveness of hormonal contraception",
        "Pregnancy and contraceptive use among women participating in the FEM-PrEP trial",
        "Preexposure prophylaxis is efficacious for HIV-1 prevention among women using depot medroxyprogesterone acetate for contraception",
        "HIV protective efficacy and correlates of tenofovir blood concentrations in a clinical trial of PrEP for HIV prevention",
        "Antiretroviral prophylaxis for HIV prevention in heterosexual men and women",
        "Tenofovir-based preexposure prophylaxis for HIV infection among African women",
        "Failure of daily tenofovir to prevent HIV transmission or the establishment of a significant viral reservoir despite continued antiretroviral therapy",
        "The effect of cyproterone acetate on serum testosterone, LH, FSH, and prolactin in male sexual offenders"
    ],
    "affiliation": [
        {
            "affiliation-city": "Durham",
            "@id": "60120612",
            "affilname": "FHI 360",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60120612",
            "affiliation-country": "United States"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60028190",
            "affilname": "Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Atlanta",
            "@id": "60021658",
            "affilname": "Centers for Disease Control and Prevention",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60021658",
            "affiliation-country": "United States"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60016965",
            "affilname": "The HIV Netherlands Australia Thailand Research Collaboration",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60016965",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Washington, D.C.",
            "@id": "60008275",
            "affilname": "United States Agency for International Development",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60008275",
            "affiliation-country": "United States"
        }
    ],
    "funding": [
        "HIV-NAT",
        "United States Agency for International Development",
        "University of North Carolina",
        "PEPFAR"
    ]
}